Jump to navigation
Activate excellence. Activate innovation. Activate success.
Aquinox Pharmaceuticals, Inc.
A clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation and cancer.
News and Media
December 17, 2013
Aquinox Pharmaceuticals commences Phase 2 clinical trial of AQX-1125 in Chronic Obstructive Pulmonary Disease
July 23, 2013
Aquinox Pharmaceuticals commences Phase II clinical trial of AQX-1125 in Bladder Pain Syndrome/Interstitial Cystitis